[1] |
WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun.
Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules
[J]. Chinese General Practice, 2025, 28(30): 3787-3795.
|
[2] |
BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang.
Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China
[J]. Chinese General Practice, 2025, 28(30): 3741-3746.
|
[3] |
QIN Bangguo, SUN Jin, LI Man, QIU Jiaojiao, CHENG Bokai, ZHU Ping, WANG Shuxia.
Relationship between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio and Left Ventricular Hypertrophy in a Community-based Hypertensive Population
[J]. Chinese General Practice, 2025, 28(30): 3753-3760.
|
[4] |
ZHANG Yunuo, LI Ruibin, WANG Wei.
Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(26): 3264-3270.
|
[5] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
[6] |
HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang.
The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients
[J]. Chinese General Practice, 2025, 28(26): 3248-3258.
|
[7] |
YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng.
Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome
[J]. Chinese General Practice, 2025, 28(26): 3258-3263.
|
[8] |
YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le.
Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural
[J]. Chinese General Practice, 2025, 28(25): 3137-3143.
|
[9] |
TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang.
Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3096-3103.
|
[10] |
TANG Shangfeng, HUANG Yangzhen, PAN Yangyang, ZHENG Yanxi, XIONG Zhongbao, ZHANG Kangkang, SONG Jia, WEI Yilin, WANG Chunying, DONG Heng, CHEN Manwei, QING Hua.
Specification for the Integration of Healthcare and Prevention Services in Hypertension at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3089-3095.
|
[11] |
YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan.
Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
[J]. Chinese General Practice, 2025, 28(24): 3053-3058.
|
[12] |
WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening.
Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention
[J]. Chinese General Practice, 2025, 28(24): 2985-2992.
|
[13] |
WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan.
Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension
[J]. Chinese General Practice, 2025, 28(24): 2972-2978.
|
[14] |
HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian.
Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions
[J]. Chinese General Practice, 2025, 28(24): 2968-2971.
|
[15] |
LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin.
Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2852-2860.
|